OTCM
CHMX
, Last price
USD
Name
NEXT-ChemX Corp
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
26.12%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
Net income
-2m
L-23.17%
CFO
-2m
L+181.33%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NEXT-ChemX Corporation in July 2021. NEXT-ChemX Corporation was incorporated in 2014 and is headquartered in Las Vegas, Nevada. NEXT-ChemX Corporation operates as a subsidiary of NEXT-ChemX Texas.
Legal address
C/O INCORP SERVICES, INC.
3773 HOWARD HUGHES PKWY STE 500S
LAS VEGAS, NV 89169-6014
US
3773 HOWARD HUGHES PKWY STE 500S
LAS VEGAS, NV 89169-6014
US
Headquarters
C/O Incorp Services Inc.
3773 Howard Hughes Parkway
Suite 500s
Las Vegas, NV 89169-6014
US
3773 Howard Hughes Parkway
Suite 500s
Las Vegas, NV 89169-6014
US
Previous name
ALLYME GROUP, INC.
Previous name
Wewin Group Corp.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||